System, method, and computer program product for detecting neurodegeneration using differential tractography
Described are a system, method, and computer program product for detecting neurodegeneration using differential tractography and treating neurological disorders accordingly. The method includes obtaining a first diffusion magnetic resonance imaging (MRI) scan of the brain of the patient and obtaining a plurality of diffusion MRI scans of a group of other brains. The method also includes generating a control diffusion MRI scan based on the plurality of diffusion MRI scans of the group of other brains. The method further includes determining a first anisotropy of first neural tracks of the first diffusion MRI scan and a second anisotropy of second neural tracks of the control diffusion MRI scan. The method further includes determining a differential by comparing the first anisotropy to the second anisotropy and identifying at least one neurological disorder based on the differential and a location of the first neural tracks in the brain of the patient.
1. A computer-implemented method for detecting neurodegeneration in a patient, comprising:
obtaining, with at least one processor, a first diffusion magnetic resonance imaging (MRI) scan of the brain of the patient;
obtaining, with at least one processor, a plurality of diffusion MRI scans of a group of other brains;
generating, with at least one processor, a control diffusion MRI scan based on the plurality of diffusion MRI scans of the group of other brains;
determining, with at least one processor, a first anisotropy of first neural tracks of the first diffusion MRI scan and a second anisotropy of second neural tracks of the control diffusion MRI scan, wherein anisotropy is measured using an anisotropic spin distribution function and is a value of spin density of restricted anisotropic diffusion at a given diffusion orientation within a given displacement;
determining, with at least one processor, a differential by comparing the first anisotropy to the second anisotropy; and
identifying, with at least one processor, at least one neurological disorder based on the differential and a location of the first neural tracks in the brain of the patient;
wherein the differential comprises at least a 15% difference of the first anisotropy from the second anisotropy.
2. A system comprising at least one server computer including at least one processor, the at least one server computer programmed and/or configured to:
obtain a first diffusion magnetic resonance imaging (MRI) scan of the brain of the patient;
obtain a plurality of diffusion MRI scans of a group of other brains;
generate a control diffusion MRI scan based on the plurality of diffusion MRI scans of the group of other brains;
determine a first anisotropy of first neural tracks of the first diffusion MRI scan and a second anisotropy of second neural tracks of the control diffusion MRI scan, wherein anisotropy is measured using an anisotropic spin distribution function and is a value of spin density of restricted anisotropic diffusion at a given diffusion orientation within a given displacement;
determine a differential by comparing the first anisotropy to the second anisotropy; and
identify at least one neurological disorder based on the differential and a location of the first neural tracks in the brain of the patient;
wherein the differential comprises at least a 15% difference of the first anisotropy from the second anisotropy.
3. A computer program product comprising at least one non-transitory computer-readable medium including program instructions that, when executed by at least one processor, cause the at least one processor to:
obtain a first diffusion magnetic resonance imaging (MRI) scan of the brain of the patient;
obtain a plurality of diffusion MRI scans of a group of other brains;
generate a control diffusion MRI scan based on the plurality of diffusion MRI scans of the group of other brains;
determine a first anisotropy of first neural tracks of the first diffusion MRI scan and a second anisotropy of second neural tracks of the control diffusion MRI scan, wherein anisotropy is measured using an anisotropic spin distribution function and is a value of spin density of restricted anisotropic diffusion at a given diffusion orientation within a given displacement;
determine a differential by comparing the first anisotropy to the second anisotropy; and
identify at least one neurological disorder based on the differential and a location of the first neural tracks in the brain of the patient;
wherein the differential comprises at least a 15% difference of the first anisotropy from the second anisotropy.
4. The method of claim 1 , wherein the control diffusion MRI scan is generated based on an average of the plurality of diffusion MRI scans of the group of other brains.
5. The method of claim 1 , wherein the first anisotropy is a measure of a segment of the first neural tracks having a length of at least 10 mm, and the second anisotropy is a measure of a segment of the second neural tracks having a length of at least 10 mm.
6. The method of claim 1 , wherein the first anisotropy is a measure of a segment of the first neural tracks having a length of at least 50 mm, and the second anisotropy is a measure of a segment of the second neural tracks having a length of at least 50 mm.
7. The method of claim 1 , wherein the differential comprises at least a 30% difference of the first anisotropy from the second anisotropy.
8. The method of claim 1 , wherein the first anisotropy comprises a value of spin density less than a value of spin density of the second anisotropy.
9. The method of claim 1 , wherein the location of the first neural tracks is in a cingulum region, a corpus callosum region, a corticostriatal pathway, or a corticospinal pathway of the brain of the patient, and wherein the at least one neurological disorder comprises Huntington's disease.
10. The system of claim 2 , wherein the control diffusion MRI scan is generated based on an average of the plurality of diffusion MRI scans of the group of other brains.
11. The system of claim 2 , wherein the first anisotropy is a measure of a segment of the first neural tracks having a length of at least 50 mm, and the second anisotropy is a measure of a segment of the second neural tracks having a length of at least 50 mm.
12. The system of claim 2 , wherein the differential comprises at least a 30% difference of the first anisotropy from the second anisotropy.
13. The system of claim 2 , wherein the first anisotropy comprises a value of spin density less than a value of spin density of the second anisotropy.
14. The system of claim 2 , wherein the location of the first neural tracks is in a cingulum region, a corpus callosum region, a corticostriatal pathway, or a corticospinal pathway of the brain of the patient, and wherein the at least one neurological disorder comprises Huntington's disease.
15. The computer program product of claim 3 , wherein the control diffusion MRI scan is generated based on an average of the plurality of diffusion MRI scans of the group of other brains.
16. The computer program product of claim 3 , wherein the first anisotropy is a measure of a segment of the first neural tracks having a length of at least 50 mm, and the second anisotropy is a measure of a segment of the second neural tracks having a length of at least 50 mm.
17. The computer program product of claim 3 , wherein the differential comprises at least a 30% difference of the first anisotropy from the second anisotropy.
18. The computer program product of claim 3 , wherein the location of the first neural tracks is in a cingulum region, a corpus callosum region, a corticostriatal pathway, or a corticospinal pathway of the brain of the patient, and wherein the at least one neurological disorder comprises Huntington's disease.
19. A method of treating a neurological disorder in a patient, comprising:
receiving, from a computing device comprising the computer program product of claim 3 , an identification of the at least one neurological disorder; and
treating, based on the identification, the at least one neurological disorder.
20. The method of claim 19 , wherein the neurological disorder is Huntington's Disease.
21. The method of claim 20 , wherein the differential of the first neural tracks in the brain of the patient is measured in the cingulum, corpus callosum, corticostriatal pathway, corticospinal pathway, or whole brain of the patient.